Vice chair of the company’s executive committee, Joaquin Duato, will transition into the role of CEO and a board member, according to an Aug. 19 news release.
Mr. Gorsky was named chair and CEO of Johnson & Johnson in 2012. He led the company’s growth in orthopedic medical technology. In the second quarter of this year, Johnson & Johnson’s orthopedics sales hit $2.2 billion, jumping 53.4 percent year-over-year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.